Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus
暂无分享,去创建一个
[1] B. Hahn. Antibodies to DNA. , 1998, The New England journal of medicine.
[2] M. Satoh,et al. Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus. , 1998, Clinical immunology and immunopathology.
[3] S. Iwata,et al. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. , 1997, Journal of immunology.
[4] P. Musiani,et al. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. , 1997, The American journal of pathology.
[5] H. Nagafuchi,et al. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. , 1997, Journal of immunology.
[6] M. Satoh,et al. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. , 1996, Journal of immunology.
[7] R. Flavell,et al. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. , 1996, Journal of immunology.
[8] W. Strober,et al. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response , 1996, The Journal of experimental medicine.
[9] M. Retter,et al. Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. , 1996, Journal of immunology.
[10] A. Kumar,et al. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Rudikoff,et al. Interleukin 6 is essential for in vivo development of B lineage neoplasms , 1995, The Journal of experimental medicine.
[12] A. Lanzavecchia,et al. CD40 ligand‐independent B cell activation revealed by CD40 ligand‐deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation , 1995, European journal of immunology.
[13] D. Malide,et al. Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. , 1995, Human pathology.
[14] A. Rolink,et al. An interleukin‐6 transgene expressed in B lymphocyte lineage cells overcomes the T cell‐dependent establishment of normal levels of switched immunoglobulin isotypes , 1995, European journal of immunology.
[15] J. Banchereau,et al. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. , 1995, Journal of immunology.
[16] C. Mohan,et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. , 1995, Journal of immunology.
[17] M. Satoh,et al. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane , 1994, The Journal of experimental medicine.
[18] D. Wofsy,et al. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. , 1994, The Journal of clinical investigation.
[19] G. Ciliberto,et al. Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.
[20] H. Nagafuchi,et al. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. , 1993, Journal of immunology.
[21] C. Franceschi,et al. Increased cytokine production in mononuclear cells of healthy elderly people , 1993, European journal of immunology.
[22] B. Kiberd. Interleukin-6 receptor blockage ameliorates murine lupus nephritis. , 1993, Journal of the American Society of Nephrology.
[23] C. Mohan,et al. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus , 1993, The Journal of experimental medicine.
[24] R. Eisenberg,et al. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. , 1993, Journal of immunology.
[25] M. Alarcón‐Riquelme,et al. Macrophage depletion decreases IgG anti‐DNA in cultures from (NZB · NZW)F1 spleen cells by eliminating the main source of IL‐6 , 1993, Clinical and experimental immunology.
[26] T. Hirano,et al. Abnormal distribution of IL-6 receptor in aged MRL/lpr mice: elevated expression on B cells and absence on CD4+ cells. , 1992, International immunology.
[27] J. Williams,et al. Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: inhibition by indomethacin. , 1992, Blood.
[28] M. Lohmann‐Matthes,et al. Expansion and high proliferate potential of the macrophage system throughout life time of lupus‐prone NZB/W and MRL lpr/lpr mice. Lack of down‐regulation of extramedullar macrophage proliferation in the postnatal period , 1991, European journal of immunology.
[29] S. Akira,et al. Age-associated increase in interleukin 6 in MRL/lpr mice. , 1991, International immunology.
[30] Y. Koishihara,et al. Immunologic abnormality in NZB/W Fl mice. Thymus‐independent expansion of B cells responding to interleukin‐6 , 1990, Clinical and experimental immunology.
[31] J. Renauld,et al. Materials and Methods Briefdefinitive Report , 2022 .
[32] M. Jourdan,et al. Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. , 1990, Arthritis and rheumatism.
[33] R. Eisenberg,et al. Autoantibodies in chronic graft versus host result from cognate T-B interactions , 1990, The Journal of experimental medicine.
[34] A. Muraguchi,et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. , 1989, Journal of immunology.
[35] D. Pisetsky,et al. Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. , 1989, Journal of immunology.
[36] C. Fisher,et al. Quantitation and IgG subclass distribution of antichromatin autoantibodies in SLE mice. , 1988, Clinical immunology and immunopathology.
[37] P. Sehgal,et al. Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts , 1987, The Journal of experimental medicine.
[38] T. Hirano,et al. TETSUYA TAGA , YOSHIKAZU KAWANISHI , 2003 .
[39] D. Pisetsky,et al. Antibodies to DNA. A perspective. , 1986, Arthritis and rheumatism.
[40] R. Nordan,et al. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. , 1986, Science.
[41] R. Dziarski. Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. I. In vitro studies. , 1982, Journal of immunology.
[42] R. Sontheimer,et al. An immunofluorescence assay for double-stranded DNA antibodies using the Crithidia luciliae kinetoplast as a double-stranded DNA substrate. , 1978, The Journal of laboratory and clinical medicine.
[43] P. Lambert,et al. Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes , 1977, The Journal of experimental medicine.
[44] I. Mackay,et al. Autoimmunity in a rural community. , 1972, Clinical and experimental immunology.
[45] M. Satoh,et al. Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera. , 1995, Journal of immunological methods.
[46] T. Hirano,et al. Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[47] V. Agnello,et al. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. , 1974, The American journal of pathology.